Mutations leading to a severe reduction of PPA2 activity results in early onset mitochondriopathy with lactic acidosis, seizures, muscular hypotonia and cardiac arrhythmia leading to an early death, commonly within the first 2 years of life [4, 5]. This evidence concerns the gene PPA2 and chronic obstructive pulmonary disease.